Price $137.18 |
Market Cap
20.93B
|
Sector Health Care |
Div. Growth
8.30%
|
|
P/E
10.4
|
P/B
3.33
|
P/S
1.93
|
Dividend %
1.40%
|
|
P/CF
-
|
P/FCF
14.5
|
Op. Cash Flow
2.29M
|
FCF
11.9
|
|
Op. Margin
23.90%
|
Net Margin
19.70%
|
ROE
33.70%
|
ROI
13.80%
|
|
ROA
16.00%
|
EPS Growth
105.80%
|
Current Ratio
1.7
|
Debt/Equity
59.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Generex Biotechnology Corporat (GNBT) | $0.05 | - | - | 7.6M | Strong Buy |
| Biomerica, Inc. (BMRA) | $4.25 | - | - | 48.8M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.56 | - | - | 68.5M | Strong Buy |
| Puma Biotechnology Inc (PBYI) | $2.51 | - | - | 130M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $62.46 | - | 3.50% | 138.77B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
